An embryo, 5 or 6 days after fertilization, with an inner cell mass.
« Back to Glossary IndexBlastocyst
« Back to Glossary Index
- Listen Now to ARC Fertility’s Dr. David Adamson on Medvale TV Megaphone Episode: “Evolution of Reproductive Medicine and the Future of Fertility Care”
In a recent episode of MEGAPHONE by Medvale Media, David Adamson, MD, Founder and CEO of ARC Fertility, expounds upon the profound transformation of reproductive medicine over the past several decades—technologically, socially and culturally. - Marching Forward: Why Employers Should Recognize Endometriosis Awareness Month
Endometriosis Awareness Month is perfectly placed in March while we celebrate International Woman’s Day. Focusing awareness on the community of nearly 200 million… Read more: Marching Forward: Why Employers Should Recognize Endometriosis Awareness Month - Global Fertility Trends: Workforce Impacts and ARC Fertility’s Solutions
The global decline in fertility rates is no longer a future concern—it is a present-day challenge with profound implications for employers worldwide. Fertility rates… Read more: Global Fertility Trends: Workforce Impacts and ARC Fertility’s Solutions - Love, Family and Fertility: Supporting Every Employee’s Dream This Valentine’s Day
Love and family are central to employees’ lives, shaping identities and guiding aspirations. Valentine’s Day is a time to honor love in… Read more: Love, Family and Fertility: Supporting Every Employee’s Dream This Valentine’s Day - Embracing Employee Menopause Benefits: A Strategic Approach for Workplace Inclusivity and Talent Retention
David Adamson, M.D.* As employers strive to foster inclusive work environments and enhance employee well-being, menopause benefits are emerging as a key… Read more: Embracing Employee Menopause Benefits: A Strategic Approach for Workplace Inclusivity and Talent Retention